This article provides a description of the rationale and processes adopted by the Gulf Coast Health Alliance: Health Risks related to the Macondo Spill consortium to evaluate and communicate the risk of exposure to polycyclic aromatic hydrocarbons (PAHs) in seafood over several years following the Deepwater Horizon disaster and subsequent oil spill. We examined gaps in knowledge associated with PAH toxicity following exposure to petrogenic (oil-derived) PAHs by studying the metabolic fate of PAHs and their potential toxicity using sophisticated analytical methods. Using the data generated, we developed a risk communication strategy designed to meet the needs of the stakeholder communities including a consumption guideline calculator, a web-based tool to reconcile seafood consumption with risk of adverse health effects.
YoskowitzDWMontagnaPA.Socio-economic factors that impact the desire to protect freshwater flow in the Rio Grande, USA. Wit Trans Ecol Environ2009;
122: 547–558.
2.
LowtherA (ed). National marine fisheries service, office of science and technology.
Silver Springs:
Fisheries of the United States, 2012, National Oceanic and Atmospheric Administration, US Department of Commerce.
3.
KeimME.The public health impact of industrial disasters. Am J Disaster Med2011;
6: 265–272.
4.
GohlkeJMDokeDTipreMet al.
A review of seafood safety after the Deepwater Horizon blowout. Environ Health Perspect2011;
119: 1062–1069.
5.
AguileraFMendezJPasaroEet al.
Review on the effects of exposure to spilled oils on human health. J Appl Toxicol2010;
30: 291–301.
6.
LemiereSCossu-LeguilleCBispoAet al.
DNA damage measured by the single-cell gel electrophoresis (Comet) assay in mammals fed with mussels contaminated by the ‘Erika’ oil-spill. Mutat Res2005;
581: 11–21.
7.
XiaKHagoodGChildersCet al.
Polycyclic aromatic hydrocarbons (PAHs) in Mississippi seafood from areas affected by the Deepwater Horizon Oil Spill. Environ Sci Technol2012;
46: 5310–5318.
8.
International Agency for Research on Cancer Working Group. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. In IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 92. Lyon: World Health Organization IARC, 2010.
ParkJ-HPenningTM. Polyaromatic hydrocarbons. In StadlerRHLineback ER (eds) Process-induced food toxicants; occurrence, formation, mitigation & health risks. Chap. 28, pp. 243–282. Hoboken: Wiley & Sons.
15.
HuangMPenningTM.Processing contaminants: polycyclic aromatic hydrocarbons (PAHs). In MotarjemiY (ed) Encyclopedia of food safety, 2014, pp. 416–423.
Waltham, MA:
Academic Press.
16.
GoldsteinLSWeyandEHSafeSet al.
Tumors and DNA adducts in mice exposed to benzo[a]pyrene and coal tars: implications for risk assessment. Environ Health Perspect1998;
106: 1325–1330.
17.
SchneiderKRollerMKalberlahFet al.
Cancer risk assessment for oral exposure to PAH mixtures. J Appl Toxicol2002;
22: 73–83.
18.
PieterseBFelzelEWinterRet al.
PAH-CALUX, an optimized bioassay for AhR-mediated hazard identification of polycyclic aromatic hydrocarbons (PAHs) as individual compounds and in complex mixtures. Environ Sci Technol2013;
47: 11651–11659.
19.
HuangMMesarosCHackfeldLCet al.
Potential metabolic activation of representative alkylated polycyclic aromatic hydrocarbons 1-methylphenanthrene and 9-ethylphenanthrene associated with the deepwater horizon oil spill in human hepatoma (HepG2) cells. Chem Res Toxicol2017;
30: 2140–2150.
20.
HuangMMesarosCHackfeldLCet al.
Potential metabolic activation of a representative C4-alkylated polycyclic aromatic hydrocarbon retene (1-methyl-7-isopropyl-phenanthrene) associated with the deepwater horizon oil spill in human hepatoma (HepG2) cells. Chem Res Toxicol2017;
30: 1093–1101.
21.
HuangMZhangLMesarosCet al.
Metabolism of an alkylated polycyclic aromatic hydrocarbon 5-methylchrysene in human hepatoma (HepG2) cells. Chem Res Toxicol2015;
28: 2045–2058.
22.
HuangMMesarosCZhangSet al.
Potential metabolic activation of a representative C2-alkylated polycyclic aromatic hydrocarbon 6-ethylchrysene associated with the deepwater horizon oil spill in human hepatoma (HepG2) cells. Chem Res Toxicol2016;
29: 991–1002.
23.
HuangMZhangLMesarosCet al.
Metabolism of a representative oxygenated polycyclic aromatic hydrocarbon (PAH) phenanthrene-9,10-quinone in human hepatoma (HepG2) cells. Chem Res Toxicol2014;
27: 852–863.
24.
GarrisonPMTullisKAartsJMet al.
Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Toxicol Sci1996;
30: 194–203.
25.
SmithSSchecterAPapkeOet al.
Quantitation of the extracellular domain of epidermal growth factor receptor in the plasma of dioxin-exposed individuals. Am J Indust Med1998;
34: 1–5.
26.
MeadorJPSteinJEReichertWLet al.
Bioaccumulation of polycyclic aromatic hydrocarbons by marine organisms. Rev Environ Contam Toxicol1995;
143: 79–165.
27.
HitzelAPohlmannMSchwageleFet al.
Polycyclic aromatic hydrocarbons (PAH) and phenolic substances in meat products smoked with different types of wood and smoking spices. Food Chem2013;
139: 955–962.
28.
ChenSKaoTHChenCJet al.
Reduction of carcinogenic polycyclic aromatic hydrocarbons in meat by sugar-smoking and dietary exposure assessment in Taiwan. J Agric Food Chem2013;
61: 7645–7653.
29.
DingYSAshleyDLWatsonCH.Determination of 10 carcinogenic polycyclic aromatic hydrocarbons in mainstream cigarette smoke. J Agric Food Chem2007;
55: 5966–5973.
30.
SlovicP.Trust, emotion, sex, politics, and science: surveying the risk-assessment battlefield. Risk Anal1999;
19: 689–701.
31.
SullivanAAJCroisantSHowarthMet al.Building and maintaining a citizen science network with fishermen and fishing communities post deepwater horizon oil disaster using a CBPR approach. New Solut2018;
28: 416–447.
32.
SlovicP.Perception of risk. Science1987;
236: 280–285.
33.
PetersESlovicPHibbardJHet al.
Why worry? Worry, risk perceptions, and willingness to act to reduce medical errors. Health Psychol2006;
25: 144–152.
34.
MeirsKWHowarthMV.Environmentally overburdened gulf state residents lack access to environmental specialty care. New Solut2018;
28: 448–462.
35.
PalingJ.Strategies to help patients understand risks. BMJ2003;
327: 745–748.
